$OCUL 8-K SEC Filings

Filed On	Filing
16 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 14, 2026, Sanjay Nayak, M.B.B.S., Ph.D., Chief Strategy Officer of Ocular Therapeutix, Inc. (the “Company”), notified the Company of his resignation from the Company, effective October 16, 2026, to become the Chief Executive O...
03 Aug 2026	8-K: Results of Operations and Financial Condition
12 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
05 May 2026	8-K: Results of Operations and Financial Condition
27 Feb 2026	8-K: Regulation FD Disclosure
05 Feb 2026	8-K: Results of Operations and Financial Condition
23 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
18 Dec 2025	8-K: Other Events
05 Dec 2025	8-K: Other Events
04 Nov 2025	8-K: Results of Operations and Financial Condition
30 Sep 2025	8-K: Entry into a Material Definitive Agreement; Other Events
30 Sep 2025	8-K: Other Events
05 Aug 2025	8-K: Results of Operations and Financial Condition
11 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +2 more
05 May 2025	8-K: Results of Operations and Financial Condition
03 Mar 2025	8-K: Results of Operations and Financial Condition
14 Feb 2025	8-K: Departure/Election of Directors or Officers; Compensation
14 Nov 2024	8-K: Results of Operations and Financial Condition
09 Oct 2024	8-K: Departure/Election of Directors or Officers; Compensation
03 Sep 2024	8-K: Departure/Election of Directors or Officers; Compensation

Comments